Search

everythinglearnresearchcommunity

for

Search:↓

Topical prostaglandin analogues may improve hair density in androgenetic alopecia, but more research is needed.

A 10-year-old girl with hair and eyelash loss showed significant regrowth after treatment.

Pharmacists play a crucial role in improving treatment outcomes and staying updated on various health conditions.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

TH07 effectively promotes hair regrowth in androgenic alopecia with high patient satisfaction and no major side effects.

TH07 treatment is promising for hair growth, with higher satisfaction in males.

The study suggests that analyzing DNA can help treat hair loss, but more research is needed.

DNA analysis can help tailor alopecia treatment.

TH07 is a topical combination of finasteride, latanoprost, and minoxidil, and shows promise.

New treatments show promise for hair loss, especially JAK inhibitors for alopecia areata.

Using travoprost for glaucoma may cause extra hair growth and darker skin around the eyes, but these effects can reverse after stopping the drug.

There are several promising treatments for hair loss, including dutasteride, latanoprost, ketoconazole shampoo, anti-androgens, laser/light treatment, and platelet-rich plasma, but more research is needed.

Different hair loss treatment ingredients work well with TrichoTech™ vehicles for 3 to 6 months, making them good for use in hair treatments.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Direct-to-consumer teledermatology is not effectively reaching underserved populations due to language, technology, and insurance barriers.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Using a teletriage system greatly increased access to skin care for uninsured Latino immigrants at a clinic.

Hispanic patients in the USA have lower survival rates for melanoma compared to non-Hispanic Whites.

All immigrant workers in the study had skin problems, with fungal nail infections, athlete's foot, and acne or folliculitis being most common, affecting their quality of life, yet they didn't seek medical help.

Hair, skin, and nails supplement use nearly doubled from 2011 to 2020, with higher usage among young adults, females, and certain ethnic groups.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

People with alopecia areata face different healthcare access and experiences based on their race and ethnicity.

Hispanic and Black patients are underrepresented in alopecia areata clinical trials.

Tailoring facial plastic surgery to different ethnic groups ensures natural and satisfactory results.

Pseudofolliculitis causes painful bumps and dark spots from shaving, especially in people with curly hair, and can be treated by changing shaving habits and using specific topical treatments.

Making platelet-rich plasma gel is cheap, safe, and easy when done by trained professionals.

Gender identity doesn't determine who people are attracted to or their sexual practices.